Manchester Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$560K Sell
467
-1,468
-76% -$1.5M 0.1% 75
2026
Q1
$1.78M Buy
1,935
+16
+0.8% +$16.2K 0.34% 43
2025
Q4
$2.06M Buy
1,919
+41
+2% +$39.2K 0.39% 38
2025
Q3
$1.43M Buy
1,878
+375
+25% +$279K 0.29% 53
2025
Q2
$1.17M Buy
1,503
+552
+58% +$429K 0.25% 46
2025
Q1
$786K Buy
951
+302
+47% +$251K 0.18% 53
2024
Q4
$501K Buy
649
+107
+20% +$88.6K 0.11% 59
2024
Q3
$480K Buy
542
+21
+4% +$18.9K 0.1% 59
2024
Q2
$472K Buy
521
+28
+6% +$22.4K 0.12% 58
2024
Q1
$384K Buy
493
+42
+9% +$29.9K 0.1% 64
2023
Q4
$263K Buy
451
+44
+11% +$25.7K 0.07% 80
2023
Q3
$219K Buy
+407
New +$210K 0.06% 85
2021
Q2
Sell
-454
Closed -$85K 383
2021
Q1
$85K Buy
454
+12
+3% +$2.35K 0.04% 123
2020
Q4
$75K Buy
442
+205
+86% +$30.6K 0.05% 117
2020
Q3
$35K Hold
237
0.03% 170
2020
Q2
$39K Sell
237
-100
-30% -$15.3K 0.03% 147
2020
Q1
$47K Sell
337
-20
-6% -$2.75K 0.03% 121
2019
Q4
$47K Buy
+357
New +$41.4K 0.02% 147
2019
Q3
Sell
-357
Closed -$40K 264
2019
Q2
$40K Buy
+357
New +$42K 0.02% 163

Other funds holding LLY

Manchester Financial's LLY Position: Q2 2026 in Review

Manchester Financial reduced its Eli Lilly (LLY) stake by 76% in Q2 2026, selling an estimated $1.5M and leaving 467 shares worth $560K. The position accounts for 0.1% of the portfolio, ranked #75.

Manchester Financial first reported a position in LLY in Q2 2019 and has held it in 19 quarters since. The position peaked at $2.06M in Q4 2025. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Manchester Financial held 467 shares of Eli Lilly worth $560K as of Q2 2026.
  • Manchester Financial sold 1,468 Eli Lilly shares in Q2 2026, an estimated $1.5M.
  • Eli Lilly made up 0.1% of Manchester Financial's portfolio in Q2 2026, its #75 holding.
  • Manchester Financial first reported a position in Eli Lilly in Q2 2019 and has held it in 19 quarters since.
  • Manchester Financial's Eli Lilly position peaked at $2.06M in Q4 2025.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Manchester Financial's 13F filing for Q2 2026, filed 17 Jul 2026.